Metraipolis › archive › dc_fb7dc242aa2d

Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report — Europe PMC PMID:41852509

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41852509
DOI
10.3389/fneph.2026.1772736
License (as archived)
solo-consultazione
Archived
2026-11-05T04:13:13.724Z
SHA-256 of the archived text
32146643d3b4ed21dcd2c5f44bd9fbaab3a84cc9e9159ed17fd2378974cffdc3
Stable URL of this page
https://metraipolis.com/documento/dc_fb7dc242aa2d

How to cite

Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report — Europe PMC PMID:41852509 — Europe PMC (en), https://europepmc.org/article/MED/41852509 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb7dc242aa2d (Metraipolis archive dc_fb7dc242aa2d, sha256 32146643d3b4ed21dcd2c5f44bd9fbaab3a84cc9e9159ed17fd2378974cffdc3)
BibTeX
@misc{dcfb7dc242aa2d,
  title = {Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report — Europe PMC PMID:41852509},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41852509},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb7dc242aa2d; sha256 32146643d3b4ed21dcd2c5f44bd9fbaab3a84cc9e9159ed17fd2378974cffdc3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41852509. Agents can read the archived copy with the MCP tool read_document.